Search research articles
Contact Us
Filters
Showing results (21-30 of 173) with videos related to
Page
of 18
Sort By:
Brain Sciences
|
March 25, 2022
Impact of the COVID-19 Pandemic on Patients with Parkinson's Disease from the Perspective of Treating Physicians-A Nationwide Cross-Sectional Study
Andreas Wolfgang Wolff, Bernhard Haller, Antonia Franziska Demleitner, et al.
Molecular Neurobiology
|
January 7, 2016
Attenuation of Axonal Degeneration by Calcium Channel Inhibitors Improves Retinal Ganglion Cell Survival and Regeneration After Optic Nerve Crush
Vinicius T Ribas, Jan C Koch, Uwe Michel, et al.
Frontiers in Neuroscience
|
September 21, 2018
Circulating miRNAs as Diagnostic Biomarkers for Parkinson's Disease
Anna Elisa Roser, Lucas Caldi Gomes, Jonas Schünemann, et al.
Journal of Molecular Neuroscience : MN
|
April 7, 2011
JNK isoforms differentially regulate neurite growth and regeneration in dopaminergic neurons in vitro
Lars Tönges, Veronique Planchamp, Jan-Christoph Koch, et al.
Brain Pathology (Zurich, Switzerland)
|
January 11, 2016
Altered Expression of Growth Associated Protein-43 and Rho Kinase in Human Patients with Parkinson's Disease
Kim-Ann Saal, Dagmar Galter, Sigrun Roeber, et al.
Journal of Visualized Experiments : Jove
|
March 29, 2012
Clinical testing and spinal cord removal in a mouse model for amyotrophic lateral sclerosis (ALS)
René Günther, Martin Suhr, Jan C Koch, et al.
Journal of Neurochemistry
|
October 31, 2012
X-ray fluorescence analysis of iron and manganese distribution in primary dopaminergic neurons
Tanja Dučić, Elisabeth Barski, Murielle Salome, et al.
Autophagy
|
May 12, 2010
Acute axonal degeneration in vivo is attenuated by inhibition of autophagy in a calcium-dependent manner
Jan C Koch, Johanna Knöferle, Lars Tönges, et al.
Nature Protocols
|
November 5, 2011
Imaging of rat optic nerve axons in vivo
Jan C Koch, Johanna Knöferle, Lars Tönges, et al.
CNS Drugs
|
February 28, 2024
SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants
Andreas W Wolff, Jörg Peine, Josef Höfler, et al.
Page
of 18
Search research articles
Search
Showing results (21-30 of 173) with videos related to
Sort By:
Page
of 18
Brain Sciences
|
March 25, 2022
Impact of the COVID-19 Pandemic on Patients with Parkinson's Disease from the Perspective of Treating Physicians-A Nationwide Cross-Sectional Study
Andreas Wolfgang Wolff, Bernhard Haller, Antonia Franziska Demleitner, et al.
Molecular Neurobiology
|
January 7, 2016
Attenuation of Axonal Degeneration by Calcium Channel Inhibitors Improves Retinal Ganglion Cell Survival and Regeneration After Optic Nerve Crush
Vinicius T Ribas, Jan C Koch, Uwe Michel, et al.
Frontiers in Neuroscience
|
September 21, 2018
Circulating miRNAs as Diagnostic Biomarkers for Parkinson's Disease
Anna Elisa Roser, Lucas Caldi Gomes, Jonas Schünemann, et al.
Journal of Molecular Neuroscience : MN
|
April 7, 2011
JNK isoforms differentially regulate neurite growth and regeneration in dopaminergic neurons in vitro
Lars Tönges, Veronique Planchamp, Jan-Christoph Koch, et al.
Brain Pathology (Zurich, Switzerland)
|
January 11, 2016
Altered Expression of Growth Associated Protein-43 and Rho Kinase in Human Patients with Parkinson's Disease
Kim-Ann Saal, Dagmar Galter, Sigrun Roeber, et al.
Journal of Visualized Experiments : Jove
|
March 29, 2012
Clinical testing and spinal cord removal in a mouse model for amyotrophic lateral sclerosis (ALS)
René Günther, Martin Suhr, Jan C Koch, et al.
Journal of Neurochemistry
|
October 31, 2012
X-ray fluorescence analysis of iron and manganese distribution in primary dopaminergic neurons
Tanja Dučić, Elisabeth Barski, Murielle Salome, et al.
Autophagy
|
May 12, 2010
Acute axonal degeneration in vivo is attenuated by inhibition of autophagy in a calcium-dependent manner
Jan C Koch, Johanna Knöferle, Lars Tönges, et al.
Nature Protocols
|
November 5, 2011
Imaging of rat optic nerve axons in vivo
Jan C Koch, Johanna Knöferle, Lars Tönges, et al.
CNS Drugs
|
February 28, 2024
SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants
Andreas W Wolff, Jörg Peine, Josef Höfler, et al.
Page
of 18